MediLink Therapeutics has signed an exclusive licensing agreement with Roche for the development and commercialisation of ...

The Walt Disney Co.’s newly announced licensing agreement with OpenAI marks a pivotal moment at the intersection of ...

Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ...

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions ...

Nimbus Therapeutics announced it has entered into a multi-year research collaboration and $1.3 exclusive license agreement ...

After prematurely ending two phase 3 depression trials last year, Relmada Therapeutics has formally given up on the asset they were testing. The Florida-based biotech terminated its license agreement ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Ideaya Biosciences (IDYA) announced that it has entered into an exclusive license agreement for SHR-4849, a novel DLL3-targeting Topo-I-payload ADC program with Jiangsu Hengrui Pharmaceuticals. Under ...

Walt Disney (DIS) Company and OpenAI have reached an agreement for Disney to become the “first major content licensing partner” on Sora, OpenAI’s short-form generative AI video platform, the companies ...

On this Ropes & Gray podcast, licensing and collaboration partner Hannah England and antitrust partner Lisa Kaltenbrunner discuss how EU antitrust rules impact non-competes and other exclusivity ...

Whether it is requested for advertising, business partnering, or distribution, a data license is often at the center of today’s business arrangements. A data license involves granting another entity ...

The agreement covers selected matches and video content from competitions organized under AFFA’s authority during the license ...